TrialHaematologica2019

Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group.

Naghmeh Niktoreh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.